UNIVERSITY OF MIAMI

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: https://continue.miami.edu/packagedetail.aspx

Clinical Trials

Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation

Phase 4

Completed

Conditions: Living-Donor Kidney Transplant

Interventions: Drug: Campath-1H
Drug: Thymoglobulin
Drug: Daclizumab

First Posted Date: 2008-05-21

Last Posted Date: 2023-09-14

Lead Sponsor: University of Miami

Target Recruit Count: 38

Registration Number: NCT00681343

Locations: 🇺🇸
University of Miami Division of Transplantation, Miami, Florida, United States

Safety of Vitamin D Supplementation in Older Persons

Phase 3

Completed

Conditions: Vitamin D Deficiency

Interventions: Dietary Supplement: cholecalciferol (vitamin D)

First Posted Date: 2008-05-21

Last Posted Date: 2017-01-26

Lead Sponsor: University of Miami

Target Recruit Count: 105

Registration Number: NCT00681590

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Three Interacting Single Nucleotide Polymorphisms (SNPs) and the Risk of Preterm Birth in Black Families

Terminated

Conditions: Premature Birth

Interventions: Genetic: Blood spot specimens will be drawn

First Posted Date: 2008-05-12

Last Posted Date: 2015-12-17

Lead Sponsor: University of Miami

Target Recruit Count: 258

Registration Number: NCT00675753

Locations: 🇺🇸
Broward Medical Center, Ft. Lauderdale, Florida, United States
🇺🇸
Broward General Medical Center, Ft Lauderdale, Florida, United States

Primary Tube Versus Trabeculectomy Study

Phase 4

Completed

Conditions: Glaucoma

Interventions: Procedure: Tube shunt surgery
Procedure: Trabeculectomy
Drug: Mitomycin C

First Posted Date: 2008-04-24

Last Posted Date: 2022-10-19

Lead Sponsor: University of Miami

Target Recruit Count: 242

Registration Number: NCT00666237

Locations: 🇺🇸
St. Louis University, Saint Louis, Missouri, United States
🇺🇸
New York Eye and Ear Infirmary, New York, New York, United States
🇺🇸
University of Virginia, Charlottesville, Virginia, United States

and more 13 locations

Effects of Leptin Replacement in Children

Phase 2

Completed

Conditions: Obesity
Diabetes
Metabolic Syndrome

Interventions: Drug: Recombinant methionyl human leptin

First Posted Date: 2008-04-16

Last Posted Date: 2020-02-13

Lead Sponsor: University of Miami

Target Recruit Count: 1

Registration Number: NCT00659828

Locations: 🇺🇸
University of Miami, Center on Pharmacogenomics, Miami, Florida, United States

Effects of Human Leptin Replacement

Phase 2

Completed

Conditions: Diabetes
Metabolic Syndrome
Obesity

Interventions: Drug: Recombinant methionyl human leptin

First Posted Date: 2008-04-14

Last Posted Date: 2020-02-13

Lead Sponsor: University of Miami

Target Recruit Count: 3

Registration Number: NCT00657605

Locations: 🇺🇸
University of Miami Miller School of Medicine, Center on Pharmacogenomics, Miami, Florida, United States

Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Imiquimod, 5% cream

First Posted Date: 2008-03-19

Last Posted Date: 2018-03-22

Lead Sponsor: University of Miami

Target Recruit Count: 3

Registration Number: NCT00638651

Locations: 🇺🇸
Mohs, Dermatologic and Laser Surgery, Miami, Florida, United States

A Waitlist-Controlled Trial of the Unified Protocol for the Treatment of Emotional Disorders in Adolescents

Not Applicable

Completed

Conditions: Depression
Anxiety Disorders

Interventions: Behavioral: Unified Protocol for Adolescents (UP-A)

First Posted Date: 2008-03-05

Last Posted Date: 2014-12-19

Lead Sponsor: University of Miami

Target Recruit Count: 51

Registration Number: NCT00628888

Locations: 🇺🇸
Child and Adolescent Mood and Anxiety Treatment (CAMAT) Program, Miami, Florida, United States

Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus

Recruiting

Conditions: Mixed Connective Tissue Disease (MCTD)
Systemic Lupus Erythematosus (SLE)

First Posted Date: 2007-12-28

Last Posted Date: 2024-03-01

Lead Sponsor: University of Miami

Target Recruit Count: 400

Registration Number: NCT00582881

Locations: 🇺🇸
University of Miami Miller School of Medicine, Miami, Florida, United States

Vaccine Therapy in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy

Phase 1

Terminated

Conditions: Lung Cancer

Interventions: Biological: Allogeneic B7.1/HLA-A1
Other: Placebo

First Posted Date: 2007-09-24

Last Posted Date: 2017-10-16

Lead Sponsor: University of Miami

Target Recruit Count: 1

Registration Number: NCT00534209

Locations: 🇺🇸
Memorial Regional Hospital, Hollywood, Florida, United States
🇺🇸
University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy